<?xml version="1.0" encoding="iso-8859-1"?>
<!-- generator="FeedCreator 1.7.2" -->
<rss version="2.0">
    <channel>
        <title>MedWorm Tags: cozaar</title>
        <description>MedWorm provides a medical RSS filtering service. Over 6000 RSS medical sources are combined and output via different filters. This feed contains the latest medical blog items that have been tagged with 'cozaar'.</description>
        <link><![CDATA[http://www.medworm.com/rss/search.php?qu=%22cozaar%22&t=%22cozaar%22&r=Exact&o=d&f=tag]]></link>
        <lastBuildDate>Sat, 03 Sep 2011 02:59:07 +0100</lastBuildDate>
        <item>
            <title>Blood Pressure Drugs Do Not Raise Cancer Risk</title>
            <link>http://www.medworm.com/index.php?rid=4893917&amp;cid=t_140747_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2FaIPonxw6_os%2F</link>
            <description>One year after an analysis of five studies involving some 60,000 patients found links between angiotensin receptor blockers and an increased risk of cancer, the FDA has now decided that these meds - which are used to control high blood pressure, do not pose such a risk.
The study, which was published in The Lancet Oncology and prompted the FDA review, found that 7.2 percent of patients on an ARB were diagnosed with cancer compared with 6 percent on a placebo, which was deemed statistically significant. Put another way: one extra cancer case would occur for every 105 people taking the meds for about four years (back story).
Most of the patients were taking Boehringer Ingelheim’s Micardis, a $1.5 billion seller, prompting an angry rebuttal from the drugmaker. Other ARBs that were studied i...</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4893917</comments>
            <pubDate>Thu, 02 Jun 2011 19:21:10 +0100</pubDate>
            <guid isPermaLink="false">4893917</guid>        </item>
        <item>
            <title>Generic Drugs: Not So Cheap</title>
            <link>http://www.medworm.com/index.php?rid=3935799&amp;cid=t_140747_87_f&amp;fid=39187&amp;url=http%3A%2F%2Fgetbetterhealth.com%2Fgeneric-drugs-not-so-cheap%2F2010.09.05</link>
            <description>I received the following e-mail from a patient (paraphrased):
Dear Dr. Fisher,
Thank you for trying to switch me from lisinopril to generic losartan (Cozaar) to help me with the irritating cough that has been nagging me since I was placed on lisinopril. I did not pick up my prescription, though. At nearly $200 for a three-month supply, I&amp;#8217;ve decided to live with the cough, since the same amount of lisinopril costs me about $12.
-Ms. Patient
Interesting how the generic drug market for some drugs only marginally discounts prices. Since the companies that make generics did not have to absorb research and development costs, how do they justify the exorbitant prices? Simple: The middlemen still have to get theirs.
-WesMusings of a cardiologist and cardiac electrophysiologist.

			
			*This...</description>
            <author>Better Health</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3935799</comments>
            <pubDate>Sun, 05 Sep 2010 16:00:00 +0100</pubDate>
            <guid isPermaLink="false">3935799</guid>        </item>
        <item>
            <title>Blood Pressure Drugs Linked To Increased Cancer</title>
            <link>http://www.medworm.com/index.php?rid=3659157&amp;cid=t_140747_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2FjA9j-WiJtWE%2F</link>
            <description>A new analysis of five previous studies involving about 60,000 patients found links between angiotensin receptor blockers, or ARBs, which are widely used blood pressure drugs, to an increased risk of cancer. Specifically, 7.2 percent of patients on an ARB were diagnosed with cancer compared with 6 percent on a placebo, which was deemed statistically significant.
The study, which was published in The Lancet Oncology, determined that one extra cancer case will occur for every 105 people taking the meds for about four years, although there isn&amp;#8217;t enough info to know if the risk disappears after the drugs are stopped. Interestingly, there was no difference in the rate of cancer deaths in people on the drugs compared to those not on them. 
&amp;#8220;The risk for the individual patient is mode...</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3659157</comments>
            <pubDate>Mon, 14 Jun 2010 12:15:47 +0100</pubDate>
            <guid isPermaLink="false">3659157</guid>        </item>
        <item>
            <title>Medical Assistant Stupid, Pharmacist Not</title>
            <link>http://www.medworm.com/index.php?rid=2447572&amp;cid=t_140747_97_f&amp;fid=35606&amp;url=http%3A%2F%2Fwww.theangriestpharmacist.com%2F2009%2F05%2F31%2Fmedical-assistant-stupid-pharmacist-not%2F</link>
            <description>Quick post today.
Answered the phone today and it was a &amp;#8220;nurse for Dr. Sayed.&amp;#8221;
&amp;#8220;Oh really?&amp;#8221; [Knowing she wasn't a nurse] &amp;#8220;What&amp;#8217;s your name?&amp;#8221; [Linda] &amp;#8220;And are you an RN or LPN?&amp;#8221; 
&amp;#8220;Welll, I guess I&amp;#8217;m just an M.A. - I&amp;#8217;m in nursing school though&amp;#8221;
&amp;#8220;Guess? &amp;#8230; Okay then - on your way. What do we need today?&amp;#8221; [I didn't go for the kill and say, 'So you're NOT a nurse then are you?' -- She knew she was beaten]
&amp;#8220;Jeff Gordon, birthday is 8/4/1971, needs his Cozaar 20mg refilled. Directions are 1 po daily. And give him 2 additional refills.&amp;#8221; [Most of you already see the problem. I wrote it exactly like this. My brain was shut off momentarily as I enjoyed my flawless victory from moments earlier.]
...</description>
            <author>The Angriest Pharmacist</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2447572</comments>
            <pubDate>Sun, 31 May 2009 22:10:05 +0100</pubDate>
            <guid isPermaLink="false">2447572</guid>        </item>
        <item>
            <title>Merck Denies Caving On UK Cozaar Pricing</title>
            <link>http://www.medworm.com/index.php?rid=807038&amp;cid=t_140747_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmalot%2F%7E3%2F145504563%2F</link>
            <description>The drugmaker slashed the price of its blood pressure medication by up to one third in the UK, but denies the move was related to a government report on drug pricing, PharmaFocus reports.
The blockbuster hypertension treatment has been on the market for more than 10 years and is one of the most widely prescribed angiotensin II receptor blockers (ARB) in the UK. Coincidentally, ARBs were among a number of drug classes identified in the Office of Fair Trading&amp;#8217;s report on pharmaceutical pricing earlier this year as being priced significantly out of line with patient benefits.
Merck announced the price cut shortly after the government responded to the OFT report - saying it would overhaul the current drug pricing system - but the drugmaker insists the timing was purely coincidental. A Me...</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=807038</comments>
            <pubDate>Sat, 18 Aug 2007 13:56:44 +0100</pubDate>
            <guid isPermaLink="false">807038</guid>        </item>
    </channel>
</rss>

